130 related articles for article (PubMed ID: 12581154)
21. The 3p21.3 tumor suppressor RBM5 resensitizes cisplatin-resistant human non-small cell lung cancer cells to cisplatin.
Li P; Wang K; Zhang J; Zhao L; Liang H; Shao C; Sutherland LC
Cancer Epidemiol; 2012 Oct; 36(5):481-9. PubMed ID: 22609235
[TBL] [Abstract][Full Text] [Related]
22. RBM5 promotes exon 4 skipping of AID pre-mRNA by competing with the binding of U2AF65 to the polypyrimidine tract.
Jin W; Niu Z; Xu D; Li X
FEBS Lett; 2012 Nov; 586(21):3852-7. PubMed ID: 23017209
[TBL] [Abstract][Full Text] [Related]
23. Conformational Dynamics from Ambiguous Zinc Coordination in the RanBP2-Type Zinc Finger of RBM5.
Soni K; MartÃnez-Lumbreras S; Sattler M
J Mol Biol; 2020 Jun; 432(14):4127-4138. PubMed ID: 32450081
[TBL] [Abstract][Full Text] [Related]
24. In vivo evidence that RBM5 is a tumour suppressor in the lung.
Jamsai D; Watkins DN; O'Connor AE; Merriner DJ; Gursoy S; Bird AD; Kumar B; Miller A; Cole TJ; Jenkins BJ; O'Bryan MK
Sci Rep; 2017 Nov; 7(1):16323. PubMed ID: 29176597
[TBL] [Abstract][Full Text] [Related]
25. RIZ1, but not the alternative RIZ2 product of the same gene, is underexpressed in breast cancer, and forced RIZ1 expression causes G2-M cell cycle arrest and/or apoptosis.
He L; Yu JX; Liu L; Buyse IM; Wang MS; Yang QC; Nakagawara A; Brodeur GM; Shi YE; Huang S
Cancer Res; 1998 Oct; 58(19):4238-44. PubMed ID: 9766644
[TBL] [Abstract][Full Text] [Related]
26. The two single nucleotide polymorphisms in the H37/RBM5 tumour suppressor gene at 3p21.3 correlated with different subtypes of non-small cell lung cancers.
Oh JJ; Koegel AK; Phan DT; Razfar A; Slamon DJ
Lung Cancer; 2007 Oct; 58(1):7-14. PubMed ID: 17606309
[TBL] [Abstract][Full Text] [Related]
27. RBM5 as a putative tumor suppressor gene for lung cancer.
Sutherland LC; Wang K; Robinson AG
J Thorac Oncol; 2010 Mar; 5(3):294-8. PubMed ID: 20186023
[TBL] [Abstract][Full Text] [Related]
28. 3p21.3 tumor suppressor gene RBM5 inhibits growth of human prostate cancer PC-3 cells through apoptosis.
Zhao L; Li R; Shao C; Li P; Liu J; Wang K
World J Surg Oncol; 2012 Nov; 10():247. PubMed ID: 23158838
[TBL] [Abstract][Full Text] [Related]
29. Lentiviral vector-mediated RBM5 overexpression downregulates EGFR expression in human non-small cell lung cancer cells.
Su Z; Yin J; Zhao L; Li R; Liang H; Zhang J; Wang K
World J Surg Oncol; 2014 Dec; 12():367. PubMed ID: 25441176
[TBL] [Abstract][Full Text] [Related]
30. RBM10 regulates alternative splicing.
Inoue A; Yamamoto N; Kimura M; Nishio K; Yamane H; Nakajima K
FEBS Lett; 2014 Mar; 588(6):942-7. PubMed ID: 24530524
[TBL] [Abstract][Full Text] [Related]
31. Overexpression of RBM5 induces autophagy in human lung adenocarcinoma cells.
Su Z; Wang K; Li R; Yin J; Hao Y; Lv X; Li J; Zhao L; Du Y; Li P; Zhang J
World J Surg Oncol; 2016 Feb; 14():57. PubMed ID: 26923134
[TBL] [Abstract][Full Text] [Related]
32. A novel PHD-finger motif protein, p47ING3, modulates p53-mediated transcription, cell cycle control, and apoptosis.
Nagashima M; Shiseki M; Pedeux RM; Okamura S; Kitahama-Shiseki M; Miura K; Yokota J; Harris CC
Oncogene; 2003 Jan; 22(3):343-50. PubMed ID: 12545155
[TBL] [Abstract][Full Text] [Related]
33. Autoregulation of RBM10 and cross-regulation of RBM10/RBM5 via alternative splicing-coupled nonsense-mediated decay.
Sun Y; Bao Y; Han W; Song F; Shen X; Zhao J; Zuo J; Saffen D; Chen W; Wang Z; You X; Wang Y
Nucleic Acids Res; 2017 Aug; 45(14):8524-8540. PubMed ID: 28586478
[TBL] [Abstract][Full Text] [Related]
34. RBM5 and p53 expression after rat spinal cord injury: implications for neuronal apoptosis.
Zhang J; Cui Z; Feng G; Bao G; Xu G; Sun Y; Wang L; Chen J; Jin H; Liu J; Yang L; Li W
Int J Biochem Cell Biol; 2015 Mar; 60():43-52. PubMed ID: 25578565
[TBL] [Abstract][Full Text] [Related]
35. p53 transactivation is involved in the antiproliferative activity of the putative tumor suppressor RBM5.
Kobayashi T; Ishida J; Musashi M; Ota S; Yoshida T; Shimizu Y; Chuma M; Kawakami H; Asaka M; Tanaka J; Imamura M; Kobayashi M; Itoh H; Edamatsu H; Sutherland LC; Brachmann RK
Int J Cancer; 2011 Jan; 128(2):304-18. PubMed ID: 20309933
[TBL] [Abstract][Full Text] [Related]
36. The nuclear splicing factor RNA binding motif 5 promotes caspase activation in human neuronal cells, and increases after traumatic brain injury in mice.
Jackson TC; Du L; Janesko-Feldman K; Vagni VA; Dezfulian C; Poloyac SM; Jackson EK; Clark RS; Kochanek PM
J Cereb Blood Flow Metab; 2015 Mar; 35(4):655-66. PubMed ID: 25586139
[TBL] [Abstract][Full Text] [Related]
37. Expression of RBM5-related factors in primary breast tissue.
Rintala-Maki ND; Goard CA; Langdon CE; Wall VE; Traulsen KE; Morin CD; Bonin M; Sutherland LC
J Cell Biochem; 2007 Apr; 100(6):1440-58. PubMed ID: 17131366
[TBL] [Abstract][Full Text] [Related]
38. Alternative splicing of the imprinted candidate tumor suppressor gene ZAC regulates its antiproliferative and DNA binding activities.
Bilanges B; Varrault A; Mazumdar A; Pantaloni C; Hoffmann A; Bockaert J; Spengler D; Journot L
Oncogene; 2001 Mar; 20(10):1246-53. PubMed ID: 11313869
[TBL] [Abstract][Full Text] [Related]
39. Genotype-dependent radiosensitivity: clonogenic survival, apoptosis and cell-cycle redistribution.
Williams JR; Zhang Y; Zhou H; Russell J; Gridley DS; Koch CJ; Little JB
Int J Radiat Biol; 2008 Feb; 84(2):151-64. PubMed ID: 18246483
[TBL] [Abstract][Full Text] [Related]
40. The 630-kb lung cancer homozygous deletion region on human chromosome 3p21.3: identification and evaluation of the resident candidate tumor suppressor genes. The International Lung Cancer Chromosome 3p21.3 Tumor Suppressor Gene Consortium.
Lerman MI; Minna JD
Cancer Res; 2000 Nov; 60(21):6116-33. PubMed ID: 11085536
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
